{"id":141613,"date":"2023-02-14T08:52:15","date_gmt":"2023-02-14T13:52:15","guid":{"rendered":"https:\/\/44.250.171.167\/?p=141613"},"modified":"2023-02-14T08:52:45","modified_gmt":"2023-02-14T13:52:45","slug":"brooks-laboratories-ltd-nse-brooks-ltd-q3-fy23-results-out-total-income-fell-20-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-nse-brooks-ltd-q3-fy23-results-out-total-income-fell-20-yoy\/","title":{"rendered":"Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY"},"content":{"rendered":"\n

Brooks Laboratories Limited (NSE: BROOKS)<\/a> is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. The company manufactures a range of products on a third-party basis for several pharmaceutical companies. Its product portfolio includes 26 dry powder injections, 31 liquid injections, five tablets, and two dry syrups, including Carbapenems products like Inj Ertapenem and Inj Meropenem, and Liquid Injectables such as Inj Nandrolone Decanoate, Inj Aceclofenac, and Inj Midazolam.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

The company’s revenue from operations for Q3FY23 was 15.39 crore, while its total income was 15.40 crore. The company’s total expenses for the quarter were 26.93 crore, resulting in a net loss of 9.48 crore. The earnings per share (EPS) for the quarter was Rs. 2.03. The company’s revenue from operations decreased from the previous quarter, which was 18.08 crore in Q2FY23. The total income for Q3FY23 also decreased from the previous quarter, which was 18.2 crore in Q2FY23. The decrease in revenue and total income could be attributed to various factors such as a decrease in sales, lower prices of products, or increased competition in the market.<\/p>\n\n\n\n

Brooks Laboratories Ltd. reported a decrease in revenue, total income, and net profit, as well as an increase in total expenses for Q3FY23 compared to the previous quarter. The company will need to implement measures to increase revenue and decrease expenses to improve its financial performance in the coming quarters.<\/p>\n","protected":false},"excerpt":{"rendered":"

Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. The company manufactures a range […]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[1115],"class_list":["post-141613","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":136955,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q2-results-released-revenue-down-15-74-yoy\/","url_meta":{"origin":141613,"position":0},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q2 Results Released! | Revenue DOWN 15.74% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":136962,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q1-results-released-revenue-down-23-21-yoy\/","url_meta":{"origin":141613,"position":1},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":136967,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q4fy22-results-released-revenue-up-94-55-yoy\/","url_meta":{"origin":141613,"position":2},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":142717,"url":"https:\/\/alphastreet.com\/india\/earnings-brooks-laboratories-ltd-nse-brooks-q3fy23-results-out-total-income-fell-20-yoy\/","url_meta":{"origin":141613,"position":3},"title":"Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY","author":"Divyansh_Kasana","date":"February 24, 2023","format":false,"excerpt":"Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions. These products are used in different therapeutic segments, such as anti-bacterial, antibiotics, anti-gastric, anti-malarial, and life-saving\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":143944,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-revolutionizes-healthcare-industry-with-groundbreaking-research-and-innovation\/","url_meta":{"origin":141613,"position":4},"title":"Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!","author":"Divyansh_Kasana","date":"April 21, 2023","format":false,"excerpt":"Stock Data: TickerNSE: BROOKS & BSE:\u00a0533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd is a contract-based pharmaceutical manufacturing company with a diversified product portfolio that includes dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions used in\u2026","rel":"","context":"In "Research Summary"","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":153640,"url":"https:\/\/alphastreet.com\/india\/sakar-healthcare-ltd-q1fy24-1-fall-in-profits\/","url_meta":{"origin":141613,"position":5},"title":"Sakar Healthcare Ltd Q1FY24; 1% fall in Profits","author":"Chirag Gupta","date":"August 14, 2023","format":false,"excerpt":"Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets\/ capsules, oral liquid syrups, dry powder injectables and syrups. The company also operates as a contract development and manufacturing organization (CDMO) for various leading pharmaceutical companies. Financial Results: Sakar Healthcare Ltd reported Revenues\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-986.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=141613"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141613\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=141613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=141613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=141613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}